FIELD: hepatology. SUBSTANCE: hepatoprotector called Maksar is administered in dose 60-120 mg three times a day over a 20-40 days period. EFFECT: enhanced treatment efficiency and enlarged choice of national hepatoprotectors. 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING CHRONIC HEPATITIS | 1995 |
|
RU2112535C1 |
METHOD FOR TREATING CHRONIC HEPATITIS | 2005 |
|
RU2282457C1 |
METHOD FOR TREATMENT OF CHRONIC HEPATITIS | 2005 |
|
RU2286792C1 |
METHOD FOR TREATING THE CASES OF CHRONIC VIRUS HEPATITIS | 1999 |
|
RU2180235C2 |
METHOD FOR TREATING CHRONIC VIRAL HEPATITIS | 2001 |
|
RU2192881C1 |
HEPATOPROTECTIVE AGENT | 2003 |
|
RU2244553C1 |
METHOD FOR EVALUATING FUNCTIONAL HEPATIC STATE IN PATIENTS WITH CHRONIC HEPATITIS AND CIRRHOSIS | 1999 |
|
RU2194280C2 |
METHOD FOR TREATMENT OF ALCOHOLIC LIVER DISEASES | 2004 |
|
RU2286785C2 |
METHOD FOR PREDICTING CIRRHOSIS AT CHRONIC VIRAL HEPATITIS | 2003 |
|
RU2244306C1 |
HEPATOPROTECTOR | 2011 |
|
RU2454243C1 |
Authors
Dates
2001-10-27—Published
1998-06-02—Filed